Trombogard

Trombogard may be available in the countries listed below.

Ingredient matches for Trombogard

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Trombogard in the following countries:

• Bulgaria

International Drug Name Search

Somnite

Somnite may be available in the countries listed below.

Ingredient matches for Somnite

Nitrazepam

Nitrazepam is reported as an ingredient of Somnite in the following countries:

• Bahrain


• Cyprus


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Qatar


• Saudi Arabia


• Sudan


• United Arab Emirates

International Drug Name Search

Cepime

Cepime may be available in the countries listed below.

Ingredient matches for Cepime

Cefepime

Cefepime is reported as an ingredient of Cepime in the following countries:

• Peru

International Drug Name Search

Renvela

Generic Name: sevelamer (Oral route)

se-VEL-a-mer

Commonly used brand name(s)

In the U.S.

• Renagel


• Renvela

Available Dosage Forms:

• Tablet


• Powder for Suspension


• Capsule

Therapeutic Class: Phosphate Binder

Uses For Renvela

Sevelamer is used to treat hyperphosphatemia (too much phosphate in the blood) in patients with chronic kidney disease who are on dialysis.

This medicine is available only with your doctor's prescription.

Before Using Renvela

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of sevelamer in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of sevelamer in the elderly. However, elderly patients may start at a lower dose.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Ciprofloxacin


• Levothyroxine


• Mycophenolate Mofetil

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Bowel blockage—Should not be used in patients with this condition.

• Difficulty with swallowing or other swallowing problems or


• Major surgery on the gastrointestinal tract or


• Stomach or bowel problems (e.g., constipation), severe—Use with caution. May cause serious side effects if the tablet cannot be swallowed completely and properly absorbed.

Proper Use of sevelamer

This section provides information on the proper use of a number of products that contain sevelamer. It may not be specific to Renvela. Please read with care.

Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.

Take this medicine with meals.

Follow carefully any diet program your doctor may recommend.

How to use the powder for oral suspension:

• Pour the entire contents of the packet in an empty cup.


• Mix the powder with 2 tablespoons of water for the 0.8 gram dose or 4 tablespoons of water for the 2.4 gram dose.


• Stir the mixture vigorously and drink it as soon as you can or within 30 minutes. Be sure to stir the mixture again before drinking if you decide to wait.

Use only the brand of this medicine that your doctor prescribed. Different brands may not work the same way.

If you are taking any other medicines, you may be asked to take them at least 1 hour before or 3 hours after you take sevelamer. If you need help deciding the best times to take your other medicines, ask your doctor or pharmacist.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For high phosphorus levels in the blood:
  
  • For oral dosage forms (suspension or tablets):
    
    • For patients not taking a phosphate binder:
      
      • Renagel®:
        
        • Adults—At first, 800 to 1600 milligrams (mg) three times a day with meals, depending on your blood phosphorus level. Your doctor will adjust your dose as needed.
        
        
        • Children—Use and dose must be determined by your doctor.
        
        
      
      
      • Renvela®:
        
        • Adults—At first, 800 to 1600 mg (1 to 2 tablets) or 0.8 to 1.6 grams (g) of powder for suspension three times a day with meals depending on your blood phosphorus level. Your doctor will adjust your dose as needed.
        
        
        • Children—Use and dose must be determined by your doctor.
        
        
      
      
    
    
    • For patients switching from Renagel® tablets to Renvela® powder for suspension or tablets:
      
      • Adults—Use the same dose in grams. Your doctor will adjust your dose as needed.
      
      
      • Children—Use and dose must be determined by your doctor.
      
      
    
    
    • For patients switching from calcium acetate to sevelamer, your doctor will determine the best dose for you and adjust as needed.
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using Renvela

It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.

If your symptoms do not improve or if they get worse, call your doctor.

Many people with kidney problems need to be on a special diet. To keep your kidney disease from getting worse, it is very important that you follow your special diet and take your medicines regularly, even if you are feeling better.

Renvela Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Incidence not known

• Bloody, black, or tarry stools


• heartburn


• indigestion


• nausea


• severe abdominal or stomach pain, cramping, or burning


• severe constipation


• severe vomiting


• trouble with breathing


• vomiting


• vomiting of material that looks like coffee grounds, severe and continuing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Acid or sour stomach


• belching


• bloating


• constipation


• diarrhea


• excess air or gas in the stomach or intestines


• full feeling


• passing gas


• stomach discomfort or upset

Incidence not known

• Itching skin


• rash

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Renvela side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Renvela resources

• Renvela Side Effects (in more detail)
• Renvela Use in Pregnancy & Breastfeeding
• Drug Images
• Renvela Drug Interactions
• Renvela Support Group
• 1 Review for Renvela - Add your own review/rating

• Renvela Prescribing Information (FDA)


• Renvela MedFacts Consumer Leaflet (Wolters Kluwer)


• Renvela Consumer Overview


• Sevelamer Professional Patient Advice (Wolters Kluwer)


• Sevelamer Monograph (AHFS DI)


• Renagel Consumer Overview


• Renagel Prescribing Information (FDA)

Compare Renvela with other medications

• Hyperphosphatemia of Renal Failure

Moclobemide

UK matches:

• Moclobemide 150mg Tablets (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AG02

CAS registry number (Chemical Abstracts Service)

0071320-77-9

Chemical Formula

C13-H17-Cl-N2-O2

Molecular Weight

268

Therapeutic Category

Antidepressant: Inhibitor of monoamine oxidase type A (MAO-A)

Chemical Name

Benzamide,4-chloro-N-[2-(4-morpholinyl)-ethyl]-

Foreign Names

• Moclobemidum (Latin)
• Moclobemid (German)
• Moclobemide (French)
• Moclobemida (Spanish)

Generic Names

• Moclobemide (OS: USAN, BAN)
• RO 11-1163 (IS: Roche)
• Moclobemid (PH: Ph. Helv. 10)
• Moclobemidum (PH: Ph. Helv. 10)

Brand Names

• Amira
  Alphapharm, Australia



• Apo-Moclob
  Apotex, Czech Republic



• Apo-Moclobemide
  Apotex, Canada; Apotex, New Zealand



• Auromid
  Galenika, Serbia



• Aurorix
  Meda, Austria; Meda, Belgium; Meda, Bulgaria; Meda, Switzerland; Meda, Czech Republic; Meda, Germany; Meda, Denmark; Meda, Finland; Meda, Hungary; Meda, Ireland; Meda, Iceland; Meda, Luxembourg; Meda, Luxembourg; Meda, Netherlands; Meda, Norway; Meda, Portugal; Meda, Sweden; Meda Pharma, Slovakia; Roche, Australia



• Biorix
  CBC, Taiwan



• Clobemix
  Genepharm, Australia



• Clorix
  Pharma Dynamics, South Africa



• Depnil
  Cipla Medpro, South Africa



• Eutac
  Taiwan Biotech, Taiwan



• GenRX Moclobemide
  Apotex, Australia



• Inpront
  Chile, Chile



• Manerix
  Meda, Spain; Meda, United Kingdom; Meda, Ireland



• Maorex
  Torrex, Hungary



• Maosig
  Sigma, Australia



• Mobemid
  Jelfa, Poland



• Mobemide
  Trima Unipharm, Singapore; Unipharm, Israel



• Moclamine
  Biocodex, France



• Moclix
  Hexal, Luxembourg



• Moclo A
  Sandoz, Switzerland



• Moclobemid Actavis
  Actavis, Finland; Actavis, Sweden



• Moclobemid AL
  Aliud, Germany



• Moclobemid Alternova
  Alternova, Austria; Alternova, Denmark; Alternova, Finland; Alternova, Sweden



• Moclobemid Hexal
  Hexal, Germany



• Moclobemid real
  Dolorgiet, Germany



• Moclobemid Sandoz
  Sandoz, Germany



• Moclobemid Stada
  Stada, Germany



• Moclobemid Torrex
  Torrex, Slovenia; Torrex, Slovakia



• Moclobemid
  Actavis, Norway; ratiopharm, Norway



• Moclobemid-1A Pharma
  1A Pharma, Germany



• Moclobemida Genedec
  Genedec, Portugal



• Moclobemida Teva
  Teva, Spain



• Moclobemide Actavis
  Actavis, Netherlands



• Moclobemide CF
  Centrafarm, Netherlands



• Moclobemide EG
  Eurogenerics, Luxembourg



• Moclobemide Merck
  Mylan, Netherlands



• Moclobemide Mylan
  Mylan, Belgium



• Moclobemide PCH
  Pharmachemie, Netherlands



• Moclobemide ratiopharm
  ratiopharm, Netherlands



• Moclobemide Sandoz
  Sandoz, Belgium; Sandoz, Netherlands



• Moclobemid-neuraxpharm
  Neuraxpharm, Germany



• Moclobemid-Puren
  Actavis, Germany



• Moclobemid-ratiopharm
  Ratiopharm, Germany; Ratiopharm, Finland



• Moclobemid-Teva
  Teva, Germany



• Moclobeta
  Betapharm, Germany



• Moclod
  CCPC, Taiwan



• Moclostad
  Pharmacodane, Denmark



• Mocloxil
  Anpharm, Poland



• Mocrim
  Apotex, Hungary



• Mohexal
  Sandoz, Australia



• Moklar
  Biovena, Poland



• Nu-Moclobemide
  Nu-Pharm, Canada



• PMS-Moclobemide
  Pharmascience, Canada



• Rimarex
  Sun, India

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sertraline Ranbaxy

Sertraline Ranbaxy may be available in the countries listed below.

Ingredient matches for Sertraline Ranbaxy

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertraline Ranbaxy in the following countries:

• France


• Netherlands

International Drug Name Search

Moexipril

In the US, Moexipril (moexipril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

• Moexipril


• Moexipril and hydrochlorothiazide


• Moexipril Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09AA13

CAS registry number (Chemical Abstracts Service)

0103775-10-6

Chemical Formula

C27-H34-N2-O7

Molecular Weight

498

Therapeutic Categories

Antihypertensive agent

ACE inhibitor

Chemical Name

(3S)-2-[(2S)-N-[(1S)-1-Carboxy-4-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester

Foreign Names

• Moexiprilum (Latin)
• Moexipril (German)
• Moexipril (French)
• Moexipril (Spanish)

Generic Names

• Moexipril (OS: BAN, DCF)
• RS 10085 (IS: Syntex)
• Moexipril Hydrochloride (OS: USAN, BANM)
• CI 925 (IS)
• RS 10085-197 (IS: Syntex)
• SPM 925 (IS)

Brand Names

• Cardiotensin
  Schwarz, Poland



• Enulid 15 (Moexipril and Hydrochlorothiazide)
  Rottapharm, Italy



• Femipres plus (Moexipril and Hydrochlorothiazide)
  UCB, Italy



• Femipres
  Schwarz, Italy



• Fempress
  Actavis, Germany



• Fempress plus (Moexipril and Hydrochlorothiazide)
  Actavis, Germany



• Moex
  Schwarz, Czech Republic; Schwarz, Hong Kong; Schwarz, Russian Federation; UCB, France



• Moexipril Hydrochloride and Hydrochlorthiazide (Moexipril and Hydrochlorothiazide)
  Paddock, United States; Teva USA, United States



• Moexipril Hydrochloride
  Apotex, United States; Paddock, United States; Teva USA, United States



• Perdix
  Schwarz, Israel; Schwarz, Oman; UCB Pharma, United Kingdom



• Renoprotec
  Merck, Mexico



• Uniretic (Moexipril and Hydrochlorothiazide)
  Schwarz, United States



• Univasc
  Adeka, Turkey; Pharos, Indonesia; Schwarz, Philippines; Schwarz, United States; UCB, Indonesia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Carindacilline

Carindacilline may be available in the countries listed below.

Ingredient matches for Carindacilline

Carindacillin

Carindacilline (DCF) is also known as Carindacillin (Prop.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Cadco

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cadco

Pyrantel

Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Cadco in the following countries:

• United States

International Drug Name Search